ArticleJCO clinical cancer informatics2026
Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?
Article in JCO clinical cancer informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe rapidly evolving breast cancer treatment landscape creates significant information synthesis challenges for clinicians. We evaluated whether small open-source large language models (LLMs) augmented with retrieval-augmented generation (RAG) could match proprietary model performance for clinical guideline queries.
methodsWe developed a domain-specialized RAG pipeline using HTML-structure-preserving chunking of 1,356 ASCO breast cancer guideline documents. Five LLMs were each evaluated with and without RAG: GPT-4-turbo, GPT-3.5-turbo, Qwen2.5-14B (14 billion parameters), LLaMA3-8B, and OpenBioLLM-8B. Performance was assessed using 98 expert-curated question-answer-context triplets across seven breast cancer categories. Evaluation used both rubric-based scoring (six metrics: fluency, relevance, reliability, consistency, clarity, and clinical impact) and exhaustive pairwise ranking by GPT-4-turbo as judge. Human validation was conducted with 15 practicing oncologists on a 10-query subset.
resultsRAG-enhanced Qwen2.5-14B achieved mean rubric scores of 3.77 versus 3.96 for GPT-4-turbo and pairwise ranking performance of 0.72 versus 0.81 (normalized scale). Although absolute rubric gains were modest (0.02-0.05 on a five-point scale), relative improvements in head-to-head win rates ranged from 16% to 46%. Human expert scores confirmed RAG superiority but were consistently more conservative than LLM judge scores (mean 3.81
conclusionSmall open-source LLMs with optimized RAG can approach state-of-the-art proprietary model performance for clinical decision support. This approach enables scalable, cost-effective, privacy-preserving deployment without recurrent fine-tuning, suggesting potential for real-world clinical implementation on single-graphics processing unit infrastructure under expert supervision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.